Rigvir Group announces a grant programme for the publications of clinical research, prospective or retrospetive, and case reports on oncolytic virotherapy.
A grant up to a maximum of 3000 EUR for publication in a Pubmed indexed journal and a grant up to a maximum of 1000 EUR for publication in a popular science journal. More information:
https://www.virotherapy.eu/doc/IVC_grants_EN.pdf
Rigvir Group
E-mail: pr@rigvir.com